Kai Yuan

1.5k total citations
66 papers, 1.1k citations indexed

About

Kai Yuan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kai Yuan has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Kai Yuan's work include RNA modifications and cancer (15 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Urinary Bladder and Prostate Research (13 papers). Kai Yuan is often cited by papers focused on RNA modifications and cancer (15 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Urinary Bladder and Prostate Research (13 papers). Kai Yuan collaborates with scholars based in China, United States and Australia. Kai Yuan's co-authors include Maoqiang Wang, Feng Duan, Jieyu Yan, Zhaojia Gao, Guodong Zhang, Yan Wang, Jie Yan, Yan Wang, Jinlong Zhang and Liping Guo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kai Yuan

65 papers receiving 1.1k citations

Peers

Kai Yuan
Xue‐Yi Xue China
Ashkan Mortezavi Switzerland
Koichiro Minami Japan
Sertaç Yazıcı Türkiye
Hayahito Nomi Japan
Joerg Hennenlotter Germany
Tatsuaki Yoneda Japan
Tomohiro Fujii Japan
Orhan G. Yigitbasi Türkiye
Katsunori Uchida Japan
Xue‐Yi Xue China
Kai Yuan
Citations per year, relative to Kai Yuan Kai Yuan (= 1×) peers Xue‐Yi Xue

Countries citing papers authored by Kai Yuan

Since Specialization
Citations

This map shows the geographic impact of Kai Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Yuan more than expected).

Fields of papers citing papers by Kai Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Yuan. The network helps show where Kai Yuan may publish in the future.

Co-authorship network of co-authors of Kai Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Yuan. A scholar is included among the top collaborators of Kai Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Yuan. Kai Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Qi, Bai‐Hao Chen, Chuyi Chen, et al.. (2025). Zuogui Pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage. Journal of Ethnopharmacology. 344. 119455–119455. 2 indexed citations
2.
Yang, Jiamin, Teng Liu, Guo‐ye Mo, et al.. (2024). Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function. Biomedicine & Pharmacotherapy. 171. 116166–116166. 13 indexed citations
3.
Tan, Wenle, Kai Yuan, Tao Xiang, et al.. (2023). Targeted versus Empiric Embolization for Delayed Postpancreatectomy Hemorrhage: A Retrospective Study of 312 Patients. Journal of Vascular and Interventional Radiology. 35(2). 241–250.e1. 1 indexed citations
4.
Zhao, Yi, et al.. (2023). Thymidine kinase 1 as a target is regulated by the hsa-let-7b-5p/LINC00665 axis and affects NSCLC prognosis. Heliyon. 9(11). e21328–e21328. 1 indexed citations
5.
Liu, Teng, Guo‐ye Mo, Yang Shao, et al.. (2023). Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK. Biochemical Pharmacology. 211. 115502–115502. 14 indexed citations
6.
Zhou, Yong, et al.. (2022). Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 3 indexed citations
7.
8.
Wang, Min, Huasheng Huang, Teng Liu, et al.. (2022). Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity. Frontiers in Pharmacology. 13. 1015693–1015693. 14 indexed citations
9.
Gao, Zhaojia, et al.. (2021). High KIF11 expression is associated with poor outcome of NSCLC. Tumori Journal. 108(1). 40–46. 13 indexed citations
10.
Zhang, Jinlong, et al.. (2018). Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia. BMC Urology. 18(1). 92–92. 5 indexed citations
11.
Yu, Jingping, Zhongling Wang, Changjie Pan, et al.. (2018). Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer. BMC Cancer. 18(1). 1120–1120. 26 indexed citations
12.
Chen, Minglong, Kai Yuan, Bin Chen, et al.. (2017). Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug. Contrast Media & Molecular Imaging. 2017. 1–10. 9 indexed citations
13.
Gao, Zhaojia, et al.. (2017). HIF-2α not HIF-1α overexpression confers poor prognosis in non–small cell lung cancer. Tumor Biology. 39(6). 3726132563–3726132563. 29 indexed citations
14.
Zhang, Jinlong & Kai Yuan. (2017). Progress of prostatic arterial embolization for treatment of benign prostatic hyperplasia. Zhonghua fangshexian yixue zazhi. 51(6). 477–480. 1 indexed citations
15.
Wang, Maoqiang, et al.. (2016). Benign Prostatic Hyperplasia: Cone-Beam CT in Conjunction with DSA for Identifying Prostatic Arterial Anatomy. Radiology. 282(1). 271–280. 70 indexed citations
16.
17.
18.
Zhang, Guodong, et al.. (2014). Angiographic anatomic findings of prostatic arteries in patients with benign prostatic hyperplasia. Zhonghua fangshexian yixue zazhi. 48(8). 678–681. 2 indexed citations
19.
Zhang, Kun, Kai Yuan, Hongyan Wu, et al.. (2011). Identification of Potential Markers Related to Neoadjuvant Chemotherapy Sensitivity of Breast Cancer by SELDI-TOF MS. Applied Biochemistry and Biotechnology. 166(3). 753–763. 11 indexed citations
20.
Yuan, Kai. (2010). Expression of HIF-1α and HIF-2α in non-small cell lung cancer. Zhonghua shiyan waike zazhi. 27(5). 614–616. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue‐Yi Xue Breakdown of academic impact, for papers by Ashkan Mortezavi Breakdown of academic impact, for papers by Koichiro Minami Breakdown of academic impact, for papers by Sertaç Yazıcı Breakdown of academic impact, for papers by Hayahito Nomi Breakdown of academic impact, for papers by Joerg Hennenlotter Breakdown of academic impact, for papers by Tatsuaki Yoneda Breakdown of academic impact, for papers by Tomohiro Fujii Breakdown of academic impact, for papers by Orhan G. Yigitbasi Breakdown of academic impact, for papers by Katsunori Uchida
Rankless by CCL
2026